Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?

PURPOSE OF REVIEW: COVID-19 patients have a procoagulant state with a high prevalence of thrombotic events. The hypothesis of an involvement of antiphospholipid antibodies (aPL) has been suggested by several reports. Here, we reviewed 48 studies investigating aPL in COVID-19 patients. RECENT FINDING...

Descripción completa

Detalles Bibliográficos
Autores principales: Foret, Thomas, Dufrost, Virginie, Salomon Du Mont, Lucie, Costa, Patricia, Lefevre, Benjamin, Lacolley, Patrick, Regnault, Veronique, Zuily, Stephane, Wahl, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Antiphospholipid Syndrome (S Zuily, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254447/
https://www.ncbi.nlm.nih.gov/pubmed/34218350
http://dx.doi.org/10.1007/s11926-021-01029-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254447/
https://www.ncbi.nlm.nih.gov/pubmed/34218350
http://dx.doi.org/10.1007/s11926-021-01029-3

Ejemplares similares